Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2005-12-07
Original market date: See footnote 1
1990-12-31
Product name:
SUPRAX
DIN:
02195992 Electronic product monograph is not available
Company:
AVENTIS PHARMA INC
2905 Place Louis-R. Renaud
Laval
Quebec
Canada
H7V 0A3
Class:
Human
Dosage form(s):
Powder For Solution
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.06.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01DD08 CEFIXIME
Active ingredient group (AIG) number:See footnote5
0122105001
Active ingredient(s) | Strength |
---|---|
CEFIXIME | 100 MG / 5 ML |